PatientsVille.com Logo

CHOLECYSTITIS and Clonazepam

PatientsVille

CHOLECYSTITIS Symptoms and Causes

Your gallbladder is a pear-shaped organ under your liver. It stores bile, a fluid made by your liver to digest fat. As your stomach and intestines digest food, your gallbladder releases bile through a tube called the common bile duct. The duct connects your gallbladder and liver to your small intestine.

Your gallbladder is most likely to give you trouble if something blocks the flow of bile through the bile ducts. That is usually a gallstone. Gallstones form when substances in bile harden. Rarely, you can also get cancer in your gallbladder.

Many gallbladder problems get better with removal of the gallbladder. Fortunately, you can live without a gallbladder. Bile has other ways of reaching your small intestine.

Check out the latest treatments for CHOLECYSTITIS

CHOLECYSTITIS treatment research studies

Clonazepam clinical trials, surveys and public health registries


Find Drug Side Effect reports



Clonazepam Side Effects

Completed Suicide (405)
Death (302)
Toxicity To Various Agents (290)
Cardiac Arrest (268)
Respiratory Arrest (250)
Cardio-respiratory Arrest (145)
Anxiety (141)
Dizziness (112)
Overdose (108)
Headache (93)
Somnolence (91)
Convulsion (83)
Poisoning (81)
Depression (75)
Nausea (75)
Confusional State (73)
Fatigue (70)
Agitation (69)
Insomnia (67)
Pain (64)
Dyspnoea (59)
Product Substitution Issue (58)
Tremor (57)
Asthenia (53)
Condition Aggravated (53)
Fall (52)
Diarrhoea (52)
Suicidal Ideation (51)
Suicide Attempt (50)
Feeling Abnormal (50)
Vomiting (47)
Loss Of Consciousness (46)
Intentional Overdose (46)
Malaise (44)
Abdominal Pain Upper (44)
Pyrexia (42)
Amnesia (41)
Chest Pain (39)
Hypotension (37)
Weight Increased (36)
Balance Disorder (36)
Gait Disturbance (35)
Abdominal Pain (35)
Tachycardia (35)
Weight Decreased (33)
Sedation (33)
Pain In Extremity (33)
Abnormal Behaviour (33)
Irritability (32)
Rash (32)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

CHOLECYSTITIS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Functional MRC With Eovist for Acute Cholecystitis
Condition: Acute Cholecystitis
Intervention:
Outcome Measure: Number of positive cases of acute Cholecystitis
2 Recruiting Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study
Condition: Acute Cholecystitis
Interventions: Procedure: Early cholecystectomy;   Procedure: Delayed cholecystectomy
Outcome Measures: Operative time;   Perioperative complications;   Conversion rate;   hospital stay in days;   Period of giving antibiotics in days
3 Recruiting Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy Due to Acute Cholecystitis. Is it Necessary?
Condition: Acute Cholecystitis
Interventions: Drug: Amoxicillin clavulanic;   Drug: Placebo
Outcome Measures: Incidence of infectious postoperative complications;   Number of days of hospital stay or readmissions.;   Number of surgical reinterventions or reoperations.
4 Unknown  Efficacy and Safety of Floseal for the Haemostasis During Laparoscopic Cholecystectomy in Acute Cholecystitis (GLA)
Condition: Cholecystitis, Acute
Intervention: Procedure: Laparoscopic Cholecystectomy
Outcome Measures: to evaluate the percentage of patients with complete haemostasis 10 minutes after laparoscopic application of haemostatic agent (Floseal) to the gall bladder bed.;   • Percentage of patients with complete haemostasis evaluated at 2, 4 and 6 minutes after laparoscopic application of haemostatic agent (Floseal) to the gall bladder bed.;   • Surgery time.;   • Percentage of patients with conversion from laparoscopic procedure to open laparotomy (conversion rate).;   • Percentage of patients developing post operative bleeding leading to re-operation.;   • Percentage of patients developing post operative bleeding leading to transfusion of blood;   • Percentage of patients developing post operative biliary leaking.;   • Time to drain removal.;   • Mortality.;   • Length of stay in hospital.;   • Safety evaluated as number of patients with adverse events and serious adverse events until end of the study.
5 Recruiting Laparoscopic Cholecystectomy for Acute Cholecystitis After 72 Hours of Symptoms
Condition: Acute Cholecystitis
Intervention: Procedure: Laparoscopic cholecystectomy
Outcome Measures: Global morbidity;   Postoperative complications;   Cost analysis
6 Recruiting Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study
Conditions: Acute Cholecystitis;   Acute Cholangitis
Interventions: Drug: Indocyanine Green (ICG);   Device: Near Infrared Fluorescence Cholangiography (NIRF-C)
Outcome Measures: Adverse events related to use of indocyanine green (ICG);   Anatomic identification with NIRF-C and IOC;   Procedure time
7 Unknown  Drainage is Not Necessary Procedure After Laparoscopic Cholecystectomy Due to Severe Acute Cholecystitis
Conditions: Acute Cholecystitis;   Empyema
Intervention: Procedure: Surgical drainage
Outcome Measure: frequency of postoperative complication occurrence
8 Not yet recruiting Transient ECG Changes in Patients With Acute Biliary Disease
Conditions: Acute Cholecystitis;   Biliary Colic;   Acute Cholangitis
Intervention:
Outcome Measure:
9 Not yet recruiting Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor
Conditions: Acute Cholecystitis;   Chronic Cholecystitis
Interventions: Procedure: TIVA - Hypotension;   Procedure: TIVA - Hypertension;   Procedure: TIVA - Bradycardia;   Procedure: TIVA - Tachycardia;   Procedure: INH - Hypotension;   Procedure: INH - Hypertension;   Procedure: INH - Bradycardia;   Procedure: INH - Tachycardia
Outcome Measures: Time to discharge from PACU;   Post operative Nausea and/or vomiting;   Visual Analog Scale Pain score;   ALDRETE Sedation Score;   Time to extubation
10 Recruiting The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy
Conditions: Cholelithiasis;   Cholecystitis;   Pancreatitis Biliary;   Colic of Gallbladder Without Mention of Cholecystitis
Intervention: Drug: Indocyanine Green (ICG)
Outcome Measures: operative time;   Safety of operative technique
11 Recruiting ONSD According to the Position During Laparoscopy
Conditions: Cholecystitis;   Ovarian Cyst;   Ovarian Cancer;   Uterine Myoma;   Cervical Cancer
Interventions: Drug: Desflurane;   Drug: Remifentanil;   Device: Ultrasonographic measurement of ONSD;   Procedure: Mechanical ventilation;   Procedure: Trendelenburg position - 30 degree;   Procedure: Reverse Trendelenburg position - 30 degree
Outcome Measure: ONSD and PaCO2
12 Unknown  Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department
Condition: Cholecystitis
Intervention: Other: video
Outcome Measure: knowledge and satisfaction measure
13 Recruiting Role of the Right Portal Pedicle and Rouviere's Sulcus as an Anatomic Landmark in Laparoscopic Cholecystectomy
Conditions: Gallstones;   Cholecystitis;   Polyps
Interventions: Procedure: Rouviere's sulcus;   Device: surgical instruments
Outcome Measures: complication rate;   conversion rate
14 Recruiting Efficacy of Proficiency-based Versus Free Laparoscopic Training in Cholecystectomy on a Virtual Reality Simulator
Conditions: Cholelithiasis;   Cholecystitis;   Cholecystolithiasis
Intervention: Procedure: Laparsocopic cholecystectomy
Outcome Measures: Time to extract the gall bladder.;   Serious intra-operative complications;   Safe cautery;   Total path length of right instrument
15 Unknown  Single Port Access (SPA) Cholecystectomy Versus Standard Laparoscopic Cholecystectomy
Conditions: Symptomatic Gallbladder Stones;   Cholecystitis;   Biliary Pancreatitis
Interventions: Procedure: SPA cholecystectomy;   Procedure: Laparoscopic cholecystectomy
Outcome Measures: Cosmesis, body image and quality of life scale;   Post-operative morbidity;   Post-operative pain;   Operative time
16 Recruiting Natural Orifice Transgastric Endoscopic Surgical Removal of the Gallbladder
Condition: Cholecystitis
Intervention: Procedure: NOTES assisted laparoscopic cholecystectomy
Outcome Measures: Postoperative pain;   Quality of Life
17 Unknown  Comparison of Single Trocar Cholecystectomy to Standard Laparoscopic Cholecystectomy
Condition: Cholelithiasis
Interventions: Procedure: Single trocar cholecystectomy;   Procedure: Standard laparoscopic cholecystectomy
Outcome Measures: To assess the safety and efficacy of a novel approach to minimally invasive surgery techniques.;   To assess pain associated with the single trocar approach;   To assess scar formation associated with single trocar approach
18 Recruiting A Prospective Study of a Haptic Device Evaluation of the Acute Abdomen
Condition: Acute Abdomen
Intervention:
Outcome Measures: Hardness of the abdominal wall;   temperature of the abdominal wall
19 Not yet recruiting Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP
Condition: Cholangitis
Interventions: Drug: Moxifloxacin;   Drug: ceftriaxone
Outcome Measures: cholangitis;   30 day mortality
20 Recruiting A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA
Conditions: Healthy;   SIRS
Intervention: Other: 123 I-HSA + 125 I HSA
Outcome Measures: Transcapillary Escape Rate (TER)of Albumin;   Fractional catabolic rate (FCR)